Octasa (mesalamine dr)

pCPA File Number: 22511
Negotiation Status:
Concluded with an LOI
Indication(s):
Ulcerative Colitis
Sponsor/Manufacturer:
Pendopharm, a division of Pharmascience Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: